Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 769 of 6351
-
New combo shot CagriSema shows promise for diabetes and weight loss
Disease control CompletedThis study will look at how much CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigational medicine. Doctors may not yet prescribe CagriSema. CagriSema will be compared to a "dummy" medicine (also called "placebo") tha…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
Brain pacemaker for kids with cerebral palsy? new trial tests safety
Disease control Recruiting nowThe purpose of this study is to test the safety of placing Deep Brain Stimulators (DBS) in a part of the brain called the cerebellum and using electrical stimulation of that part of the brain to treat movement symptoms related to cerebral palsy. Ten children and young adults with…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Immune cell injection takes on Hard-to-Treat leukemia
Disease control Recruiting nowThis is an open-label clinical study: phase Ia is the dose-escalation part, and phase Ib is the dose-expansion part. The phase Ia study is to evaluate the safety, tolerability, recommended phase II dose, pharmacokinetics, immunogenicity and preliminary efficacy of IBR733 cell inj…
Phase 1 • Sponsor: Imbioray (Hangzhou) Biomedicine Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug combo targets deadly thyroid cancer in small trial
Disease control Recruiting nowThis pilot phase 2 study evaluate the effectiveness and safety of pembrolizumab and lenvatinib in patients with anaplastic thyroid cancer. Patients with anaplastic thyroid cancer who are treatment-naive (BRAF-negative) and who were previously treated with chemptherapy or targeted…
Phase 2 • Sponsor: Saint Petersburg State University, Russia • Aim: Disease control
Last updated Jun 26, 2026 14:10 UTC
-
Zapping ovaries: could a quick procedure replace daily pills for PCOS infertility?
Disease control Stopped earlyA Prospective, Multicenter, Randomized, Pivotal Study of the May Health System in Transvaginal Ablation of Ovarian Tissue under Ultrasound Guidance in Women with Infertility due to Polycystic Ovary Syndrome
Sponsor: May Health • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for pancreatic cancer? drug combo trial shows promise
Disease control CompletedThis is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without budigalimab in combination with chemotherapy (gemcitabine + nab-paclitaxel) in subjects with metastatic PDAC who did not have prior t…
Phase 2 • Sponsor: Trishula Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a daily migraine pill stop attacks fast? new trial aims to find out
Symptom relief OngoingA migraine attack is a moderate or severe headache that usually occurs on one side of the head and is often accompanied by throbbing, sensitivity to light, sensitivity to sound, nausea, or other symptoms. The main goal of the study is to see if atogepant is effective, safe, and w…
Phase 3 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New injection could spare cancer patients from repeated belly drains
Symptom relief OngoingA Randomized, Controlled, Multi-Center Phase III Clinical Study to Compare the Efficacy and Safety of Recombinant Anti-EpCAM and Anti-CD3 Human-Mouse Chimeric Bispecific Antibody (M701) for Intraperitoneal Injection to Paracentesis alone in Patients with Malignant Ascites Caused …
Phase 3 • Sponsor: Wuhan YZY Biopharma Co., Ltd. • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
New study tests smarter dosing for newborns hooked on opioids
Symptom relief CompletedThis clinical trial will help us learn more about how to best care for babies with Neonatal Opioid Withdrawal Syndrome, also called NOWS. Babies with NOWS often have tremors, a hard time sleeping, excessive crying, and trouble feeding. Some babies that have NOWS need medicine. Do…
Phase 3 • Sponsor: HELP for NOWS Consortium • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New imaging technique could improve heart attack treatment outcomes
Disease control Recruiting nowThe aim of the study is to compare clinical outcomes between optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI).
Sponsor: Chonnam National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for Hard-to-Treat cancers: experimental PARP inhibitor enters human trials
Disease control OngoingThe purpose of this study is to determine if the experimental treatment with poly-ADP ribose polymerase (PARP) inhibitor, ACE-86225106 is safe, tolerable and has anti-cancer activity in adult patients with advanced solid tumors.
Phase 1/2 • Sponsor: Acerand Therapeutics (Shanghai) Limited • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New immune cell therapy targets Hard-to-Treat cancers
Disease control Recruiting nowPhase I Study, a master protocol to investigate TCR-Engineered T cells recognizing KRAS mutations in adult subjects with Unresectable, Advanced, and/or Metastatic Solid Tumors.
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Your voice may hold clues to depression – a new device listens in
Diagnosis CompletedA prospective, single arm, non-randomized, pilot clinical validation study to evaluate the ability of the Kintsugi Voice Device (the Device) to aid clinical assessment for depression by comparing its output with a diagnosis made by a clinician using the Structured Clinical Interv…
Sponsor: Kintsugi Mindful Wellness, Inc. • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
Could 3 weeks of proton therapy be as safe as 5 for breast cancer?
Disease control Recruiting nowThe purpose of this research study is to learn more about the effects of using proton radiation therapy delivered over a shorter course of treatment (3 weeks) compared with a longer, standard course of treatment (5 weeks) for women with breast cancer who require radiotherapy to t…
Phase 3 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug combo targets aggressive lymphoma in CLL patients
Disease control Recruiting nowThis is a national clinical trial, multicentric (28 centers), non-randomized phase 2 study. Population: Patients with previously untreated Richter's syndrome (RS), defined as the occurrence of an aggressive lymphoma (of diffuse large B-cell lymphoma histology) in a patient with …
Phase 2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a single injection fix bowel leakage after childbirth? new trial aims to find out
Disease control OngoingThis study evaluates the efficacy and safety of a single injection of iltamiocel (300 x 10\^6 cells) compared to a placebo in the reduction of fecal incontinence episode frequency in adult female participants with chronic fecal incontinence and a history of obstetric anal sphinct…
Phase 3 • Sponsor: Cook MyoSite • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Engineered immune cells take on deadly brain tumors
Disease control PausedThis is a dose exploration clinical trial to assess the safety and feasibility of the IL13Ra2-targeted CAR-T in glioma.
Phase 1 • Sponsor: Yang Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for head and neck cancer: drug may prevent recurrence after chemoradiation
Disease control Recruiting nowThe goal of this study is to assess the safety and effectiveness of Dostarlimab compared to Placebo in adult participants with Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Can exercise reshape body image and ease endometriosis burden?
Symptom relief CompletedThis research focuses on understanding how physical activity can improve the quality of life for women with endometriosis by enhancing their self-perception, particularly regarding their physical abilities and appearance. The study is based on the idea that improving internal per…
Sponsor: Fondation Hôpital Saint-Joseph • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Could a single shot before surgery shield your heart?
Prevention Recruiting nowThis is an investigator initiated, multi-center, open-labelled, superiority randomized controlled trial of 372 patients undergoing elective non-cardiac surgery. Recruited patients will be randomized in a 2:1 ratio to receive single subcutaneous dose of Glucagon-like Peptide-1 Rec…
Phase 4 • Sponsor: The University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC